We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$441M
AUM Growth
+$65.3M
Cap. Flow
+$17.1M
Cap. Flow %
3.89%
Top 10 Hldgs %
48.81%
Holding
93
New
22
Increased
21
Reduced
16
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 35.6%
2 Communication Services 13.84%
3 Real Estate 10.92%
4 Energy 8.35%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$136B
$35.2M 7.99%
+662,798
New +$33.8M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.19T
$26.8M 6.09%
+961,751
New +$24.3M
HOT
3
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$25.4M 5.77%
319,810
-9,363
-3% -$685K
GILD icon
4
Gilead Sciences
GILD
$181B
$23.9M 5.42%
318,246
-137,236
-30% -$9.56M
AMZN icon
5
Amazon
AMZN
$2.87T
$21M 4.78%
1,055,660
+589,220
+126% +$10.6M
A icon
6
Agilent Technologies
A
$43.4B
$20.4M 4.63%
498,791
+52,791
+12% +$2.01M
AGN
7
DELISTED
Allergan plc
AGN
$17.5M 3.98%
104,342
+102,294
+4,995% +$16M
PCP
8
DELISTED
PRECISION CASTPARTS CORP
PCP
$16.2M 3.67%
60,043
+35,977
+149% +$9.05M
HCA icon
9
HCA Healthcare
HCA
$90.5B
$14.5M 3.3%
304,646
+73,673
+32% +$3.4M
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
$14M 3.19%
439,962
+329,992
+300% +$9.97M
TNL icon
11
Travel + Leisure Co
TNL
$4.36B
$13.8M 3.14%
415,928
-247,185
-37% -$7.56M
ETN icon
12
Eaton
ETN
$156B
$12.6M 2.86%
165,504
-95,205
-37% -$6.77M
VLO icon
13
Valero Energy
VLO
$101B
$12.3M 2.78%
+243,148
New +$10.2M
AMT icon
14
American Tower
AMT
$82.1B
$12.1M 2.75%
151,859
+29,556
+24% +$2.3M
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
$12.1M 2.74%
200,617
+47,611
+31% +$2.59M
ANDV
16
DELISTED
Andeavor
ANDV
$12M 2.72%
+204,839
New +$10.7M
META icon
17
Meta Platforms (Facebook)
META
$1.47T
$11.4M 2.58%
+208,343
New +$10.5M
ADBE icon
18
Adobe
ADBE
$116B
$11.3M 2.57%
189,066
-22,721
-11% -$1.26M
CCI icon
19
Crown Castle
CCI
$32.4B
$10.6M 2.41%
+144,357
New +$10.7M
CRM icon
20
Salesforce
CRM
$211B
$9.95M 2.26%
180,207
+408
+0.2% +$21.8K
TWX
21
DELISTED
Time Warner Inc
TWX
$8.24M 1.87%
123,213
-102,500
-45% -$6.63M
DG icon
22
Dollar General
DG
$27.1B
$8.04M 1.82%
133,245
-184,552
-58% -$10.8M
CMI icon
23
Cummins
CMI
$77.8B
$7.52M 1.71%
53,361
-77,717
-59% -$10.3M
CME icon
24
CME Group
CME
$103B
$7.26M 1.65%
+92,475
New +$7.24M
ENDP
25
DELISTED
Endo International plc
ENDP
$6.98M 1.58%
+103,467
New +$5.9M

Similar funds

Partner Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Partner Investment Management held 93 positions worth $441M, up 17% from $375M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Partner Investment Management deployed $17.1M of net new capital in Q4 2013, opening 22 new positions and adding to 21 existing holdings. Its largest new stake was Bristol-Myers Squibb: 662,798 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 29% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $16.1M trimmed.

  • Partner Investment Management's largest Q4 2013 buy was Bristol-Myers Squibb: 662,798 shares worth $35.2M.
  • Partner Investment Management added most to Allergan plc in Q4 2013, an estimated $16M increase.
  • Partner Investment Management's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $16.1M.
  • Partner Investment Management fully exited CAMERON INTERNATIONAL CORPORATION in Q4 2013, selling an estimated $11M.
  • Partner Investment Management's ten largest holdings make up 49% of its $441M portfolio in Q4 2013.
  • Partner Investment Management opened 22 new positions and closed 33 in Q4 2013.
  • Partner Investment Management's portfolio value rose 17% quarter-over-quarter to $441M.

Based on Partner Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.